Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Free Cash Flow (2016 - 2026)

Corcept Therapeutics (CORT) has disclosed Free Cash Flow for 15 consecutive years, with -$17.0 million as the latest value for Q1 2026.

  • For Q1 2026, Free Cash Flow fell 463.76% year-over-year to -$17.0 million; the TTM value through Mar 2026 reached $120.1 million, down 32.13%, while the annual FY2025 figure was $141.8 million, 27.71% down from the prior year.
  • Free Cash Flow hit -$17.0 million in Q1 2026 for Corcept Therapeutics, down from $38.4 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $71.7 million in Q3 2024 and bottomed at -$17.0 million in Q1 2026.
  • Average Free Cash Flow over 5 years is $33.4 million, with a median of $35.2 million recorded in 2022.
  • Year-over-year, Free Cash Flow soared 984.05% in 2024 and then crashed 463.76% in 2026.
  • Corcept Therapeutics' Free Cash Flow stood at $33.4 million in 2022, then plummeted by 83.42% to $5.5 million in 2023, then skyrocketed by 984.05% to $59.9 million in 2024, then crashed by 35.94% to $38.4 million in 2025, then crashed by 144.2% to -$17.0 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$17.0 million, $38.4 million, and $54.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.